Tocladesine in Treating Patients With Recurrent or Refractory Multiple Myeloma
Status:
Completed
Trial end date:
1999-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of tocladesine in treating patients who
have recurrent or refractory multiple myeloma.